Child Examinations | North Tonawanda, NY

After Hour Nurse Advice Lines
phone iconPhone: (716) 807-7337
phone iconFax: (716) 213-4400
Receive our Health e-Newsletter


News for Healthier Living

Targeting CDK2 Could Boost Immunotherapy Response in Patients with a Wide Range of Cancers, According to Dana-Farber Science

New research from Dana-Farber Cancer Institute scientists suggests that cyclin-dependent kinase 2 (CDK2) inhibitors, which are currently being tested as treatments that slow the growth of a narrow range of cancers, could potentially be more broadly applicable to a wide range of cancers when combined with immunotherapy.

September 3, 2026


September 11 2026

September 10 2026

September 9 2026

September 8 2026

September 7 2026

September 5 2026

September 4 2026

September 3 2026

September 2 2026

September 1 2026

August 31 2026

August 30 2026